Breaking News Instant updates and real-time market news.

UBER

Uber

$33.97 /

+0.02 (+0.06%)

14:40
01/09/20
01/09
14:40
01/09/20
14:40

Uber to launch three new safety features in India, TechCrunch says

Uber said it is starting to launch three safety features in India as the ride-hailing giant seeks to improve its service in the market, TechCrunch's Manish Singh reports. The new features include an intervention from Uber when there is a long unplanned stop in a ride, and the rollout of a four-digit authentication code to ensure a passenger is getting into the right vehicle, Singh says. Both the features are now available to users starting today, the author says, citing an announcement from company executives at a press event in New Delhi. The company added that it will allow riders and drivers in India to record their entire ride and send it to the company if they are feeling uncomfortable, the author notes. Reference Link

UBER Uber
$33.97 /

+0.02 (+0.06%)

01/09/20 JMP Securities
Uber the most likely buyer if GrubHub gets sold, says JMP Securities
01/09/20 Deutsche Bank
GrubHub could be worth 'substantially higher' in buyout, says Deutsche Bank
01/09/20 Wedbush
GrubHub price target raised to $45 from $30 at Wedbush
01/08/20 Stifel
GrubHub's reported strategic review 'seems prudent,' says Stifel

TODAY'S FREE FLY STORIES

Downgrade
Eventbrite downgraded to Sector Perform from Outperform at RBC Capital » 05:45
02/28/20
02/28
05:45
02/28/20
05:45
EB

Eventbrite

$16.98 /

-0.74 (-4.18%)

RBC Capital analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Moderna has five potential mRNA rare disease blockbusters, says Piper Sandler » 05:42
02/28/20
02/28
05:42
02/28/20
05:42
MRNA

Moderna

$26.16 /

-3.01 (-10.32%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Gilead downgraded to Hold from Buy at DZ Bank » 05:36
02/28/20
02/28
05:36
02/28/20
05:36
GILD

Gilead

$72.66 /

-2.04 (-2.73%)

DZ Bank analyst Elmar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Nielsen downgraded to Neutral from Outperform at Baird » 05:35
02/28/20
02/28
05:35
02/28/20
05:35
NLSN

Nielsen

$18.49 /

-1.8 (-8.87%)

Baird analyst Jeffrey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Intellia Therapeutics upgraded to Outperform from Perform at Oppenheimer » 05:34
02/28/20
02/28
05:34
02/28/20
05:34
NTLA

Intellia Therapeutics

$11.69 /

-0.61 (-4.96%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
AB InBev downgraded to Neutral from Buy at Bryan Garnier » 05:33
02/28/20
02/28
05:33
02/28/20
05:33
BUD

AB InBev

$60.20 /

-6.15 (-9.27%)

Bryan Garnier analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Horizon Technology upgraded to Neutral from Sell at Compass Point » 05:31
02/28/20
02/28
05:31
02/28/20
05:31
HRZN

Horizon Technology

$11.56 /

-0.455 (-3.79%)

Compass Point analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
NeoGenomics upgraded to Strong Buy from Outperform at First Analysis » 05:31
02/28/20
02/28
05:31
02/28/20
05:31
NEO

NeoGenomics

$27.50 /

-2.51 (-8.36%)

First Analysis analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Nektar shares will end year higher than here, says Piper Sandler » 05:29
02/28/20
02/28
05:29
02/28/20
05:29
NKTR

Nektar

$20.59 /

-0.81 (-3.79%)

Nektar Therapeutics'…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Edgewell Personal Care reinstated with a Conviction Buy at Goldman Sachs » 05:26
02/28/20
02/28
05:26
02/28/20
05:26
EPC

Edgewell Personal Care

$30.46 /

-0.39 (-1.26%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Biohaven label for Nurtec is 'superior' to Ubrelvy, says Piper Sandler » 05:22
02/28/20
02/28
05:22
02/28/20
05:22
BHVN

Biohaven Pharmaceutical

$40.99 /

-3.49 (-7.85%)

, AGN

Allergan

$189.63 /

-3.53 (-1.83%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Hess Corp. removed from the US 1 List at BofA  05:19
02/28/20
02/28
05:19
02/28/20
05:19
HES

Hess Corp.

$54.97 /

-0.95 (-1.70%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Coty appoints Pierre Denis as CEO, CFO Pierre-Andre Terisse adds COO duties » 05:19
02/28/20
02/28
05:19
02/28/20
05:19
COTY

Coty

$9.67 /

-0.365 (-3.64%)

Coty announced several…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Continental Resources price target lowered to $25 from $40 at Imperial Capital » 05:18
02/28/20
02/28
05:18
02/28/20
05:18
CLR

Continental Resources

$17.50 /

-3.285 (-15.80%)

Imperial Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
HighPoint Resources downgraded to In-Line from Outperform at Imperial Capital » 05:17
02/28/20
02/28
05:17
02/28/20
05:17
HPR

HighPoint Resources

$0.68 /

-0.1455 (-17.62%)

Imperial Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Resideo upgraded to Outperform from In-Line at Imperial Capital » 05:16
02/28/20
02/28
05:16
02/28/20
05:16
REZI

Resideo

$10.28 /

+1.78 (+20.94%)

Imperial Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Mondi upgraded to Outperform from Neutral at Exane BNP Paribas » 05:13
02/28/20
02/28
05:13
02/28/20
05:13
MONDY

Mondi

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Indra Sistemas upgraded to Outperform from Neutral at Exane BNP Paribas » 05:12
02/28/20
02/28
05:12
02/28/20
05:12
ISMAY

Indra Sistemas

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Upgrade
ExlService upgraded to Neutral from Sell at Citi » 05:10
02/28/20
02/28
05:10
02/28/20
05:10
EXLS

ExlService

$74.19 /

+1.84 (+2.54%)

Citi analyst Ashwin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Dominion issues statement regarding SEC complaint » 05:09
02/28/20
02/28
05:09
02/28/20
05:09
D

Dominion

$81.27 /

-3.62 (-4.26%)

The SEC filed a complaint…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Whiting Petroleum downgraded to Hold from Buy at Stifel » 05:07
02/28/20
02/28
05:07
02/28/20
05:07
WLL

Whiting Petroleum

$1.71 /

-0.555 (-24.56%)

Stifel analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Resonant initiated with a Buy at Stifel » 05:06
02/28/20
02/28
05:06
02/28/20
05:06
RESN

Resonant

$1.62 /

-0.04 (-2.41%)

Stifel analyst Tore…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
Upgrade
Ventas upgraded to Market Perform from Underperform at Raymond James » 05:03
02/28/20
02/28
05:03
02/28/20
05:03
VTR

Ventas

$54.95 /

-4.56 (-7.66%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Welltower upgraded to Strong Buy from Market Perform at Raymond James » 05:03
02/28/20
02/28
05:03
02/28/20
05:03
WELL

Welltower

$75.61 /

-5.1 (-6.32%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Broadridge upgraded to Outperform from Market Perform at Raymond James » 05:00
02/28/20
02/28
05:00
02/28/20
05:00
BR

Broadridge

$107.73 /

-4.82 (-4.28%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.